GE HealthCare Technologies Inc. (GEHC)
Official siteHEALTHCARE • HEALTH INFORMATION SERVICES • NASDAQ
Market Cap: $37.54B
Last updated: Nov 17, 2026 at 11:06 AM ET
GE HealthCare Technologies Inc. (GEHC) Stock Forecast
Analysts expect GE HealthCare Technologies (GEHC) to earn $5.02 per share in the fiscal year ending Dec 31, 2026, on revenue of $21.86B. Of 22 analysts, 16 rate the stock Buy or Strong Buy, 6 Hold and 0 Sell or Strong Sell, for a consensus of Buy. For the fiscal year ending Dec 31, 2027, the EPS consensus is $5.50.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 22 ratings average 2.00, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 73% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 6 | 27.3% |
| Buy | 10 | 45.5% |
| Hold | 6 | 27.3% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Buy
- Total analysts
- 22
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus rises 9.6% and revenue estimates rise 4.9%.
- Fiscal year ending Dec 31, 2026
- $5.02
- EPS consensus, revenue $21.86B
- Fiscal year ending Dec 31, 2027
- $5.50
- EPS consensus, revenue $22.93B
- Next report
- Feb 8, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $5.02 | $4.99 to $5.06 | 22 | $21.86B | $21.76B to $21.92B | 21 |
| Dec 31, 2027 | $5.50 | $5.09 to $5.70 | 20 | $22.93B | $22.68B to $23.18B | 18 |
Quarterly Estimates
The EPS consensus falls from $1.59 for the quarter ending Dec 31, 2026 to $1.11 for the quarter ending Mar 31, 2027.
EPS range
Revenue range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $1.59 | $1.50 to $1.68 | 21 | $6.04B | $5.71B to $6.28B | 20 |
| Mar 31, 2027 | $1.11 | $0.99 to $1.25 | 12 | $5.37B | $5.34B to $5.39B | 9 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has risen 1.8% from $4.93.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | $5.02 | $5.02 | $4.93 | $4.93 | $4.93 | +1.9% |
| Fiscal year ending Dec 31, 2027 | $5.50 | $5.50 | $5.41 | $5.41 | $5.41 | +1.7% |
| Quarter ending Mar 31, 2027 | $1.11 | $1.12 | $1.13 | $1.13 | $1.13 | -1.7% |
Frequently Asked Questions About GEHC
What is the GEHC stock forecast?
Consensus analyst estimates put GE HealthCare Technologies's EPS at $5.02 for the fiscal year ending Dec 31, 2026, on revenue of $21.86B. The consensus rating from 22 analysts is Buy.
How do analysts rate GEHC stock?
Of 22 analysts covering GE HealthCare Technologies, 6 rate it Strong Buy, 10 Buy, 6 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.
What EPS do analysts expect from GEHC next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $5.02, with estimates from $4.99 to $5.06 from 22 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $5.50, with estimates from $5.09 to $5.70 from 20 analysts.
What revenue do analysts expect from GE HealthCare Technologies next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $21.86B, with estimates from $21.76B to $21.92B. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $22.93B, with estimates from $22.68B to $23.18B.
How many analysts cover GEHC?
22 analysts rate GE HealthCare Technologies stock, and 22 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.
GEHC pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors